Cahaba Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Cahaba Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-561	Closed	-$279K	–	159
2025 Q1	$279K	Buy	561 +5	+0.9%	+$2.71K	0.02%	120
2024 Q4	$289K	Sell	556 -4	-0.7%	-$2.2K	0.02%	120
2024 Q3	$346K	Buy	560 +2	+0.4%	+$1.18K	0.03%	110
2024 Q2	$309K	Sell	558 -25	-4%	-$14.3K	0.03%	113
2024 Q1	$339K	Buy	583 +2	+0.3%	+$1.12K	0.03%	106
2023 Q4	$308K	Sell	581 -75	-11%	-$36.3K	0.03%	103
2023 Q3	$332K	Sell	656 -8	-1%	-$4.26K	0.04%	100
2023 Q2	$346K	Sell	664 -97	-13%	-$52.3K	0.04%	102
2023 Q1	$439K	Sell	761 -48	-6%	-$27.1K	0.05%	87
2022 Q4	$446K	Hold	809	–	–	0.06%	84
2022 Q3	$410K	Sell	809 -55	-6%	-$30.8K	0.06%	83
2022 Q2	$469K	Sell	864 -127	-13%	-$69.9K	0.07%	79
2022 Q1	$547K	Sell	991 -25	-2%	-$14.4K	0.08%	73
2021 Q4	$678K	Sell	1,016 -14	-1%	-$8.74K	0.09%	64
2021 Q3	$588K	Buy	+1,030	New	+$565K	0.09%	70

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Cahaba Wealth Management's TMO Position: Q2 2025 in Review

Cahaba Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 561 shares — an estimated $279K sold.

Cahaba Wealth Management first reported a position in TMO in Q3 2021 and held it in 15 quarters. The position peaked at $678K in Q4 2021. 2,458 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Cahaba Wealth Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Cahaba Wealth Management sold 561 Thermo Fisher Scientific shares in Q2 2025, an estimated $279K.
Cahaba Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2021 and held it in 15 quarters.
Cahaba Wealth Management's Thermo Fisher Scientific position peaked at $678K in Q4 2021.
2,458 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Cahaba Wealth Management's 13F filing for Q2 2025, filed 16 Jul 2025.